OKYO Pharma CSO Patil Rajkumar V. Receives 3,363-Share Award

What Happened
Patil Rajkumar V., Chief Scientific Officer of OKYO Pharma Ltd (OKYO), was granted 3,363 shares on July 27, 2026. The award is reported at an acquisition price of $1.49 per share, for a reported aggregate value of $5,011. This transaction is coded as an award/grant (A) — an acquisition as part of compensation rather than an open‑market purchase.

Key Details

• Transaction date: 2026-07-27
• Form 4 filing date: 2026-07-29 (filed within two business days of the transaction)
• Price reported: $1.49 per share
• Shares acquired: 3,363; aggregate value: $5,011
• Transaction code: A (award/grant)
• Shares owned after transaction: not specified in the provided filing details
• Footnotes/plan details: none disclosed in the provided information (no 10b5‑1, tax‑withholding, or vesting terms shown)

Context
Equity awards to executives are commonly part of compensation packages and may be subject to vesting schedules or other restrictions; they are not the same signal as an open‑market purchase by an insider. Because this is a grant, it reflects compensation accounting rather than a direct market vote by the insider. The filing appears timely (filed two days after the transaction), which is standard for Section 16 insiders.